[Development and persistence of the humoral immune response induced by the preventive treatment with rabies vaccine (HDCS) in a group of laboratory workers]. 1982

F Ciuchini, and A Irsara, and S Pestalozza, and L Di Trani, and Z Orfei

UI MeSH Term Description Entries
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D007753 Laboratories Facilities equipped to carry out investigative procedures. Laboratory
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D011818 Rabies Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf. Encephalitic Rabies,Furious Rabies,Hydrophobia,Paralytic Rabies,Lyssa,Furious Raby,Lyssas,Rabies, Encephalitic,Rabies, Furious,Raby, Furious
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D011820 Rabies virus The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates. Rabies viruses
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

F Ciuchini, and A Irsara, and S Pestalozza, and L Di Trani, and Z Orfei
January 1978, Developments in biological standardization,
F Ciuchini, and A Irsara, and S Pestalozza, and L Di Trani, and Z Orfei
July 1978, Journal of biological standardization,
F Ciuchini, and A Irsara, and S Pestalozza, and L Di Trani, and Z Orfei
September 1980, The Journal of communicable diseases,
F Ciuchini, and A Irsara, and S Pestalozza, and L Di Trani, and Z Orfei
April 2022, Tropical medicine and infectious disease,
F Ciuchini, and A Irsara, and S Pestalozza, and L Di Trani, and Z Orfei
January 1978, Journal of biological standardization,
F Ciuchini, and A Irsara, and S Pestalozza, and L Di Trani, and Z Orfei
January 1978, Developments in biological standardization,
F Ciuchini, and A Irsara, and S Pestalozza, and L Di Trani, and Z Orfei
April 2017, Journal of virology,
F Ciuchini, and A Irsara, and S Pestalozza, and L Di Trani, and Z Orfei
November 1999, Clinical and diagnostic laboratory immunology,
F Ciuchini, and A Irsara, and S Pestalozza, and L Di Trani, and Z Orfei
March 1973, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B,
F Ciuchini, and A Irsara, and S Pestalozza, and L Di Trani, and Z Orfei
January 1982, Medycyna doswiadczalna i mikrobiologia,
Copied contents to your clipboard!